Overall, this proof-of-principle study demonstrates the critical role of mitochondrial dynamics dysfunction in CD38-upregulated activity and supports the use of this approach to prime MM cells through NAD+-lowering agents. Here, CD38 is linked to Miyoshi myopathy.